FGFR1 and breast carcinoma: Our study identified FGFR1 as the target of miR-4687-5p, which was previously reported to be downregulated in ALS (amyotrophic lateral sclerosis) [77], cystic echinococcosis [78], polycystic ovary syndrome [79], and breast cancer [80].